A new study in human and mouse cell lines shows that specific proteins that have long been studied as inhibitors of influenza can also inhibit SARS-CoV-2, the type of coronavirus that causes COVID-19. Findings of the...
Re-starting the global economy for billions of people will depend on successfully overcoming logistical challenges in the ‘last mile’ of a COVID-19 vaccine’s journey to immunisation stations, according to a new report...
A report released by the US Government Accountability Office (GAO) says supply chain issues could interfere with a smooth rollout of a COVID-19 vaccine and that the Food and Drug Administration (FDA) should disclose...
Pfizer and BioNTech — the pharmaceutical companies currently leading a phase 3 coronavirus vaccine trial, in which efficacy and safety tests are being conducted — issued a press release explaining how their vaccine...
Fewer than three quarters of people around the world say they are likely to use a vaccination against COVID-19 if one is approved by regulatory agencies, falling short of the levels required to achieve collective...
The first coronavirus 2019 (COVID-19) vaccine to be considered for emergency approval may be a month away. Pfizer chief executive officer Albert Bourla wrote in an open letter Friday morning that efficacy and safety...
Finding a vaccine for COVID-19 does not mean an automatic return to normality, experts say, warning people to be “realistic” about the challenges that remain. There may still be some time before it makes a...
An antibody test for the virus that causes COVID-19, developed by researchers at The University of Texas at Austin in collaboration with Houston Methodist and other institutions, is more accurate and can handle a much...
Children and teenagers are less likely than adults to develop severe Covid-19 or die from the disease, according to the world’s largest study of hospital patients with Covid-19. Obesity, Black ethnicity and being under...
Responding to a need to quickly develop billions of doses of lifesaving COVID-19 vaccines, a scientific team at The University of Texas at Austin has successfully redesigned a key protein from the coronavirus, and the...